GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Health and Happiness (H&H) International Holdings Ltd (HKSE:01112) » Definitions » Research & Development

Health and Happiness (H&H) International Holdings (HKSE:01112) Research & Development : HK$0 Mil (TTM As of Dec. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Health and Happiness (H&H) International Holdings Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Health and Happiness (H&H) International Holdings's Research & Development for the six months ended in Dec. 2023 was HK$0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0 Mil.


Health and Happiness (H&H) International Holdings Research & Development Historical Data

The historical data trend for Health and Happiness (H&H) International Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Health and Happiness (H&H) International Holdings Research & Development Chart

Health and Happiness (H&H) International Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Health and Happiness (H&H) International Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Health and Happiness (H&H) International Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Health and Happiness (H&H) International Holdings  (HKSE:01112) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Health and Happiness (H&H) International Holdings Research & Development Related Terms

Thank you for viewing the detailed overview of Health and Happiness (H&H) International Holdings's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Health and Happiness (H&H) International Holdings (HKSE:01112) Business Description

Traded in Other Exchanges
Address
18 Westlands Road, Suites 4007-09, 40th Floor, One Island East, Taikoo Place, Quarry Bay, Hong Kong, HKG
Health and Happiness (H&H) International Holdings Ltd manufactures and sells premium pediatric nutrition and baby-care products. The company has core business segments namely Infant formulas; Probiotic supplements; Adult nutrition and care products; Other pediatric products & Pet nutrition and care products. It generates maximum revenue from the Infant formulas segment. The Infant formulas segment comprises the production of infant formulas for children under seven years old and milk formulas for expectant and nursing mothers. Geographically, the majority is from Mainland China.
Executives
Hsbc Holdings Plc 2302 Custodian
Templeton Asset Management Ltd. 2102 Investment manager
Flying Company Limited 2201 Interest of corporation controlled by you
Ubs Trustees (b.v.i.) Limited 2301 Trustee
Luo Yun 2305 Beneficiary of a trust
Luo Fei 2307 Founder of a discretionary trust who can infl
Coliving Limited
Biostime Pharmaceuticals (china) Limited 2101 Beneficial owner

Health and Happiness (H&H) International Holdings (HKSE:01112) Headlines

No Headlines